Skip to content

ERBA Diagnostics, Inc.: 10-Q filed 2014-11-10

What ERBA Diagnostics, Inc. reported in its quarterly report filed 2014-11-10 (fiscal Q3 2014): 43 published measures, 120 facts as tagged in accession 0001437749-14-020113.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-10
Fiscal period
fiscal Q3 2014
Accession
0001437749-14-020113 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ERBA Diagnostics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-3026,402,316USD
At 2013-12-3125,874,466USD
At 2013-09-3025,644,211USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-307,962,679USD
At 2013-12-318,356,800USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-3018,439,637USD
At 2013-12-3117,517,666USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-302,286,914USD
At 2013-12-314,031,071USD
At 2013-09-303,270,017USD
At 2012-12-314,125,819USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30127,918USD92
2014-01-01 to 2014-09-30743,944USD273
2013-07-01 to 2013-09-30129,229USD92
2013-01-01 to 2013-09-30-30,490USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-1,671,623USD273
2013-01-01 to 2013-09-30-1,899,065USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-30398,560USD273
2013-01-01 to 2013-09-301,081,751USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-399,097USD273
2013-01-01 to 2013-09-30-264,233USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-30-35,117,399USD
At 2013-12-31-35,861,343USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-07-01 to 2014-09-3043,906,740shares92
2014-01-01 to 2014-09-3043,832,851shares273
2013-07-01 to 2013-09-3043,658,221shares92
2013-01-01 to 2013-09-3043,658,221shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-07-01 to 2014-09-3055,236,760shares92
2014-01-01 to 2014-09-3054,650,237shares273
2013-07-01 to 2013-09-3046,937,852shares92
2013-01-01 to 2013-09-3043,658,221shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2014-09-300USD/shares92
2014-01-01 to 2014-09-300.02USD/shares273
2013-07-01 to 2013-09-300USD/shares92
2013-01-01 to 2013-09-300USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-07-01 to 2014-09-300USD/shares92
2014-01-01 to 2014-09-300.01USD/shares273
2013-07-01 to 2013-09-300USD/shares92
2013-01-01 to 2013-09-300USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-07-01 to 2014-09-3029,133USD92
2014-01-01 to 2014-09-3088,176USD273
2013-07-01 to 2013-09-3027,294USD92
2013-01-01 to 2013-09-3079,988USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-301,778,407USD
At 2013-12-311,561,203USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-09-3051,403USD273
2013-01-01 to 2013-09-30134,000USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-30351,066USD92
2014-01-01 to 2014-09-301,154,282USD273
2013-07-01 to 2013-09-3078,541USD92
2013-01-01 to 2013-09-30229,924USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-3018,663,104USD
At 2013-12-3118,301,887USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-306,166,158USD
At 2013-12-316,753,215USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-301,843,111USD
At 2013-12-311,953,906USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-09-303,494,619USD
At 2013-12-313,494,619USD
At 2013-09-303,494,619USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-09-301,241,210USD
At 2013-12-311,480,151USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-306,385,317USD
At 2013-12-315,546,715USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-302,791,851USD92
2014-01-01 to 2014-09-308,630,461USD273
2013-07-01 to 2013-09-302,936,353USD92
2013-01-01 to 2013-09-309,274,744USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-09-307,259,095USD
At 2013-12-316,494,173USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-303,142,917USD92
2014-01-01 to 2014-09-309,784,743USD273
2013-07-01 to 2013-09-303,014,894USD92
2013-01-01 to 2013-09-309,504,668USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-01 to 2014-09-30110,325USD92
2014-01-01 to 2014-09-30686,220USD273
2013-07-01 to 2013-09-30205,398USD92
2013-01-01 to 2013-09-30933,375USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-3044,008,221shares
At 2013-12-3143,658,221shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-09-30-322,819USD
At 2013-12-31-138,943USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-09-309,731,623USD
At 2013-12-319,537,324USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-09-307,953,216USD
At 2013-12-317,976,121USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-3017,239USD
At 2013-12-3118,786USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-301,138,491USD
At 2013-12-311,027,425USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30157,051USD92
2014-01-01 to 2014-09-30832,120USD273
2013-07-01 to 2013-09-30156,523USD92
2013-01-01 to 2013-09-3049,498USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-174,971USD92
2014-01-01 to 2014-09-30560,068USD273
2013-07-01 to 2013-09-30549,994USD92
2013-01-01 to 2013-09-30158,385USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,750,267USD92
2014-01-01 to 2014-09-304,752,106USD273
2013-07-01 to 2013-09-301,403,495USD92
2013-01-01 to 2013-09-304,331,719USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-09-30735,838USD273
2013-01-01 to 2013-09-30636,494USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-07-01 to 2014-09-3020,775USD92
2014-01-01 to 2014-09-30-14,077USD273
2013-07-01 to 2013-09-30-5,663USD92
2013-01-01 to 2013-09-30-40,368USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-194,015USD92
2014-01-01 to 2014-09-30-322,162USD273
2013-07-01 to 2013-09-3077,982USD92
2013-01-01 to 2013-09-30-180,426USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2014-01-01 to 2014-09-300USD273
2013-01-01 to 2013-09-300USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-09-3051,591USD273
2013-01-01 to 2013-09-3034,494USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30918,043USD273
2013-01-01 to 2013-09-30800,695USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30881,246USD273
2013-01-01 to 2013-09-30825,862USD273

Inspect the source

Entity
ERBA Diagnostics, Inc. / CIK 0001095858
Captured
SEC response SHA-256
f1d4d8536b454af3adff8390fbd44b9f4141c1417c800c862eca646385c0daad

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001095858.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))